Related Experiment Video
Updated: May 6, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
[Diffuse large B-cell lymphoma with heart involvement: the relevance of the multidisciplinary and multiparameter
Andrea Pennacchioni1, Maria Elena Nizzoli2, Massimo Roncali3
1U.O. Cardiologia, AUSL - IRCCS Reggio Emilia.
Insights
Lymphoma patients face cardiac risks from treatment and infiltration. This study details the successful multidisciplinary management of diffuse large B-cell lymphoma with heart involvement, detected via imaging.
Area of Science:
- Cardiology
- Oncology
- Medical Imaging
Background:
- Lymphoma patients are susceptible to cardiovascular events from anthracycline cardiotoxicity and cardiac infiltration.
- Cardiac masses in lymphoma patients complicate management, posing risks of arrhythmias, heart block, ischemia, and effusion.
Purpose of the Study:
- To describe the clinical presentation of lymphoma with multifocal cardiac involvement.
- To highlight the successful multidisciplinary management of such cases.
Main Methods:
- Case report of diffuse large B-cell lymphoma with cardiac involvement.
- Utilized total body 18FDG positron emission tomography for disease staging.
- Employed a multidisciplinary approach for patient management.
Main Results:
- Successfully managed a case of diffuse large B-cell lymphoma with multifocal cardiac involvement.
- 18FDG PET imaging was crucial for identifying cardiac infiltration at staging.
- Multidisciplinary care led to a positive outcome.
Conclusions:
- Multifocal cardiac involvement in lymphoma is a complex clinical challenge.
- Early identification via advanced imaging like 18FDG PET is vital.
- Multidisciplinary management is key to successful outcomes in these high-risk patients.
Abstract:
Lymphoma patients are at high risk of cardiovascular events due to anthracycline cardiotoxicity and, in rare cases, related to heart infiltration. The presence of cardiac masses adds further complexity to the management of lymphoma patients beyond myocardial chemotherapy-related toxicity, given possible unpredictable acute complications such as arrhythmias, atrioventricular block, myocardial ischemia, pericardial effusion and cardiac tamponade. Here we describe the clinical presentation and successful multidisciplinary management of diffuse large B-cell lymphoma with multifocal cardiac involvement identified by total body 18FDG positron emission tomography performed at disease staging.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

